Disopyramide Production Cost Reports

The report provides a detailed analysis essential for establishing a disopyramide production plant. It encompasses all critical aspects necessary for disopyramide production, including the cost of disopyramide production, disopyramide plant cost, disopyramide production costs, and the overall disopyramide production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a disopyramide production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Disopyramide is a prescription antiarrhythmic medicine that is mainly used in the treatment of certain types of abnormal heart rhythms. It is primarily prescribed to manage ventricular arrhythmias, where the heart beats in an irregular or abnormal pattern. It works by helping to stabilise the electrical activity of the heart and maintain a steady heartbeat. It finds its main application in the treatment of patients who are at risk of life-threatening irregular heart rhythms and require strict medical supervision. It is often prescribed to patients who have not responded well to other antiarrhythmic drugs. Moreover, it is also sometimes used to relieve symptoms of hypertrophic obstructive cardiomyopathy, as it helps reduce the force of heart muscle contraction and improves blood flow. Additionally, it is administered in oral capsule form for long-term treatment with regular monitoring to ensure safe and effective control of cardiac rhythm disorders.

The primary factor that drives the market for disopyramide is its demand as an anti-arrhythmic agent to control irregular heartbeat associated with ventricular arrhythmias such as sustained ventricular tachycardia. Its application in managing ventricular arrhythmias and other serious irregular heartbeats that affect the heart’s ability to pump blood properly significantly supports its demand in the medical and pharmaceutical industry. Its usage to restore and maintain a normal heart rhythm by slowing electrical signals in the heart and stabilising its activity also drives its demand in the medical and healthcare sectors. Its usage as a medication in the management of hypertrophic obstructive cardiomyopathy by improving blood flow from the heart further boosts its demand in the pharmaceutical and healthcare industries.

Its demand as an effective anti-arrhythmia drug in hospital settings during the initial phase of therapy or when other anti-arrhythmic medicines are not effective also promotes its market growth. Additionally, procurement practices are influenced by factors such as the cost and availability of active pharmaceutical ingredients, strict regulatory approvals, and quality compliance standards. Manufacturing capabilities, supplier reliability, patent considerations, and stable distribution networks also play an important role in shaping industrial disopyramide procurement across global markets.

Raw Material for Disopyramide Production

According to the disopyramide production plant project report, the major raw materials for disopyramide production include benzylcyanide, 2-chloropyridine, 2-diisopropylaminoethyl chloride, sodium amide, and sulfuric acid.

Production Process of Disopyramide

The extensive disopyramide production cost report consists of the following industrial production process:

1. Production via Arylation: The production process of disopyramide begins with the arylation of benzylcyanide using 2-chloropyridine in the presence of sodium amide, forming α-phenyl-α-(2-pyridyl)acetonitrile as a main intermediate. Then, this intermediate is alkylated with 2-diisopropylaminoethyl chloride using sodium amide to introduce the diisopropylaminoethyl side chain and produce the corresponding substituted nitrile compound. Finally, the nitrile group is hydrolysed under acidic conditions with sulfuric acid, which converts it into the amide functional group and forms α-(2-diisopropylaminoethyl)-α-phenyl-2-pyridineacetamide or disopyramide as the desired product.

The compound decomposes on heating and does not exhibit a defined atmospheric boiling point.